168 related articles for article (PubMed ID: 36268318)
21. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
[TBL] [Abstract][Full Text] [Related]
22. Vitamin B12 deficiency and the knowledge and practice of physicians regarding screening for vitamin B12 deficiency among type 2 diabetic patients on metformin in selected hospitals in Riyadh, Saudi Arabia.
Alshammari AN; Iqbal R; Baksh IP
J Family Med Prim Care; 2019 Jul; 8(7):2306-2311. PubMed ID: 31463247
[TBL] [Abstract][Full Text] [Related]
23. Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study.
Losurdo G; Caccavo NLB; Indellicati G; Celiberto F; Ierardi E; Barone M; Di Leo A
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109245
[TBL] [Abstract][Full Text] [Related]
24. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis.
Jung SB; Nagaraja V; Kapur A; Eslick GD
Intern Med J; 2015 Apr; 45(4):409-16. PubMed ID: 25583062
[TBL] [Abstract][Full Text] [Related]
25. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
Koyyada A
Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
[TBL] [Abstract][Full Text] [Related]
26. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS.
Chinzon D; Domingues G; Tosetto N; Perrotti M
Arq Gastroenterol; 2022; 59(2):219-225. PubMed ID: 35830032
[TBL] [Abstract][Full Text] [Related]
27. Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.
Doell A; Walus A; To J; Bell A
Can J Hosp Pharm; 2018; 71(5):302-307. PubMed ID: 30401996
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term proton pump inhibitor therapy on hemoglobin and serum iron levels after sleeve gastrectomy.
Sharma N; Chau WY; Dobruskin L
Surg Obes Relat Dis; 2019 Oct; 15(10):1682-1689. PubMed ID: 31422079
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.
Heidelbaugh JJ
Ther Adv Drug Saf; 2013 Jun; 4(3):125-33. PubMed ID: 25083257
[TBL] [Abstract][Full Text] [Related]
30. Do acid-lowering agents affect vitamin B12 status in older adults?
Dharmarajan TS; Kanagala MR; Murakonda P; Lebelt AS; Norkus EP
J Am Med Dir Assoc; 2008 Mar; 9(3):162-7. PubMed ID: 18294598
[TBL] [Abstract][Full Text] [Related]
31. Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.
Heidelbaugh JJ; Goldberg KL; Inadomi JM
Gastroenterol Hepatol (N Y); 2009 Oct; 5(10):725-734. PubMed ID: 37967443
[TBL] [Abstract][Full Text] [Related]
32. Opportunistic Screening of Vitamin B12 Deficiency in IT Professionals Presenting for Routine Health Check-up.
Ingole JR; Patel RD; Ingole SJ; Pandave HT
J Clin Diagn Res; 2015 Dec; 9(12):OC01-2. PubMed ID: 26816929
[TBL] [Abstract][Full Text] [Related]
33. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
34. Adverse Effects of Proton Pump Inhibitors on Platelet Count: A Case Report and Review of the Literature.
Mukherjee S; Jana T; Pan JJ
Case Rep Gastrointest Med; 2018; 2018():4294805. PubMed ID: 29854491
[TBL] [Abstract][Full Text] [Related]
35. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment.
Sagar M; Janczewska I; Ljungdahl A; Bertilsson L; Seensalu R
Aliment Pharmacol Ther; 1999 Apr; 13(4):453-8. PubMed ID: 10215728
[TBL] [Abstract][Full Text] [Related]
36. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
37. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS
J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275
[TBL] [Abstract][Full Text] [Related]
38. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
39. Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?
Wakeman M; Archer DT
Diabetes Metab Syndr Obes; 2020; 13():2093-2108. PubMed ID: 32606868
[TBL] [Abstract][Full Text] [Related]
40. Vitamin B12 Deficiency Induced by the Use of Gastric Acid Inhibitors: Calcium Supplements as a Potential Effect Modifier.
Presse N; Perreault S; Kergoat MJ
J Nutr Health Aging; 2016; 20(5):569-73. PubMed ID: 27102797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
